Gribben JG, Palomba ML, Limbrick-Oldfield E, Palivela M, et al. Axicabtagene ciloleucel demonstrates superior outcomes over historically available treatments in relapsed/refractory follicular lymphoma: 5-year comparative analysis between ZUMA-5 and SCHOLAR-5. Leuk Lymphoma 2025 Dec 30:1-5. doi: 10.1080/10428194.2025.2604306.
PMID: 41467613